Inventor · disambiguated record
Laurent David
Also filed as: DAVID LAURENT
11 granted patents·4 pending applications·25 citations·filing 2004–2024
86Inventor score
Top patents by PatentIndex Score
15 records- 0195US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 0292US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 0389US10487142B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Nov 26, 2019·5 cites·3 claims
- 0488US10472415B2Antibodies specific for hyperphosphorylated tau and methods of useH LUNDBECK AS·Filed 2017·Granted Nov 12, 2019·5 cites·3 claims
- 0588US2025257124A1Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 0682US11358971B2Prodrugs of modulators of the NMDA receptorH LUNDBECK AS·Filed 2020·Granted Jun 14, 2022·1 cites·36 claims
- 0778US12129289B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Oct 29, 2024·0 cites·15 claims
- 0871US9682967B2N-substituted-5-substituted phthalamic acids as sortilin inhibitorsH LUNDBECK AS·Filed 2014·Granted Jun 20, 2017·3 cites·8 claims
- 0964US2022213117A1Prodrugs of modulators of the nmda receptorH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 1052US11466027B2Modulators of the NMDA receptorH LUNDBECK AS·Filed 2020·Granted Oct 11, 2022·0 cites·19 claims
- 1150US9321748B2Aminopyridine derived compounds as LRRK2 inhibitorsLUNDBECK & CO AS H·Filed 2013·Granted Apr 26, 2016·0 cites·19 claims
- 1247US10195186B2N-substituted-5-substituted phthalamic acids as sortilin inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 5, 2019·0 cites·14 claims
- 1342US9393248B1Aminopyridine derived compounds as LRRK2 inhibitorsLUNDBECK & CO AS H·Filed 2016·Granted Jul 19, 2016·0 cites·18 claims
- 1439US2009118336A1Pyrazole derivatives and their use as pi3k inhibitorsDAVID LAURENT·Filed 2007·Application pending·0 cites
- 1539US2006287354A1Azaindole compounds as kinase inhibitorsDAVID LAURENT·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurent David files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →